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Autophagy and senescence are two distinct cellular
responses to stress that are also tumor suppression
mechanisms. In this issue of Genes & Development,
Young and colleagues (pp. 798–803) discovered that
autophagy is induced during and facilitates the process
of senescence. Knowing now that these two pathways
are functionally intertwined sets the stage for establish-
ing how they function cooperatively in the cancer
setting.
An appropriate cellular stress response is critical for
maintaining tissue integrity and function and for prevent-
ing disease, especially cancer. Cells respond to stress with
adaptation, repair, and recovery, or are diverted into
irreversible cell cycle exit (senescence) or are eliminated
through programmed cell death (apoptosis). These cell
fate decisions are critical to deal with the emergence of
damaged and potentially dangerous cells that can cause
cancer. Defects in the cellular stress response cause the
manifestation of cellular damage and/or prevent the
senescence or elimination of damaged cells, which causes
the accumulation of mutations leading to cancer.
It is becoming clear that the cellular lysosomal degra-
dation pathway of autophagy is also a major component
of the cellular stress response. Although initially identi-
fied as a cell survival mechanism in times of nutrient
starvation, emerging evidence suggests that autophagy
can also be an important tumor suppression mechanism
(Mathew et al. 2007a; Levine and Kroemer 2008). Autoph-
agy can enable adaptation to stress through the degrada-
tion of cellular proteins and organelles to suppress
damage, maintain metabolism, and promote cellular
viability and fitness. How tumor suppression by autoph-
agy is related to other stress response pathways and
mechanisms of tumor suppression is not well understood.
Although autophagy can delay apoptosis, a role for
autophagy in senescence was not previously known.
Young et al. (2009) report here that the stress of oncogene
activation also triggers autophagy that is required for
efficient establishment of the senescence phenotype.
Thus, the two stress pathways of autophagy and senes-
cence are now functionally linked, providing new aspects
to their mechanisms of tumor suppression.
Senescence is a pathway to cell cycle exit, retooling,
and tumor suppression
Cellular senescence is a stable form of cell cycle arrest
that limits the proliferation of damaged cells. Initially
defined by the phenotype of human fibroblasts undergoing
replicative exhaustion in culture (Hayflick andMoorhead
1961), senescence can be triggered in many cell types
in response to diverse forms of cellular stress, including
as a consequence of aberrant hyperproliferative stimuli
(‘‘oncogene-induced senescence,’’ OIS) or following DNA
damage (Serrano et al. 1997; for review, see d’Adda di
Fagagna 2008). As a consequence, cellular senescence
imposes a potent barrier to tumorigenesis and contributes
to the cytotoxicity of certain anti-cancer agents (Schmitt
et al. 2002; Braig et al. 2005; Chen et al. 2005; Collado
et al. 2005; Michaloglou et al. 2005). Interestingly, sen-
escent cells have also been observed in certain aged or
damaged tissues, and have been suggested to limit cell
depletion and the decline of tissue regeneration capacity
with age (for review, see Campisi 2007). Senescence may
also act as part of a homeostaticmechanism to limit wound
healing responses following tissue damage (Krizhanovsky
et al. 2008).
The transition from a growing, proliferative state to
senescence involves gradual but massive changes in cell
physiology and protein expression (for review, see Campisi
2007). Thus, senescent cells often develop a large, flat-
tenedmorphologyandaccumulatea senescence-associated
b-galactosidase (SA-b-gal) activity that distinguishes
them from most quiescent cells. In addition, they often
down-regulate genes involved in proliferation and extra-
cellular matrix production, and up-regulate inflamma-
tory cytokines and other molecules known to modulate
the tissue microenvironment or immune response. Con-
sistent with the role of cellular senescence as a barrier to
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malignant transformation, senescent cells activate the
p53 and p16/Rb tumor suppressor pathways and are
required to various degrees in different cell types to
execute the program (Courtois-Cox et al. 2008). Whereas
p53 promotes senescence by transactivating genes that
inhibit proliferation, p16INK4a promotes senescence by
inhibiting cyclin-dependent kinases 2 and 4, thereby
preventing Rb phosphorylation and allowing Rb to
promote a global repressive heterochromatin environ-
ment that apparently silences certain proliferation-
associated genes (Serrano et al. 1997; Narita et al.
2003). Clearly, then, senescence involves substantial
cellular remodeling, but how this occurs had not been
examined.
Autophagy is a pathway for cellular self-degradation,
intracellular recycling, and tumor suppression
The autophagy pathway is a means to capture intracel-
lular proteins, protein aggregates, and organelles in spe-
cialized vesicles called autophagosomes, which are then
directed to lysosomes for degradation. There are many
purposes for autophagy that include maintenance of
energy homeostasis through intracellular recycling and
damage mitigation through the elimination of unfolded
proteins and malfunctioning organelles. Although basal
autophagy is an important housekeeping function for
normal cells, like senescence, autophagy is induced by
stress, including starvation and aging, where it plays
a vital role in preserving cellular viability (Levine and
Kroemer 2008).
Autophagy is induced in metabolically stressed, hyp-
oxic regions of tumors, where it supports tumor cell
viability (Mathew et al. 2007a). The tumor suppression
function of autophagy may result from preventing the
accumulation of damaged proteins and organelles, which
may be a source of oxidative stress and lead to genome
damage (Karantza-Wadsworth et al. 2007; Mathew et al.
2007b). Furthermore, the recycling of intracellular com-
ponents sustains cell metabolism during deprivation that
may have an indirect role in cellular protection (Jin and
White 2008). This protein and organelle quality control
function of autophagy can be thought of ultimately as
a means of cellular quality control. As such, autophagy
may preserve cellular health and fitness in stress through
catabolism, thereby limiting tumorigenesis. The damage
mitigation and metabolic homeostasis provided by
autophagy highlights the importance of the lysosomal
compartment in this process and is a conceptually novel
tumor suppression mechanism.
Autophagy induction and role in OIS
Young et al. (2009) examined human diploid fibroblasts
induced into senescence by activation of the H-ras
oncogene and found stimulation of autophagosome for-
mation. In this OIS, cells typically undergo a burst of
proliferation (‘‘the mitotic phase’’) that in this experimen-
tal paradigm spans day 1, followed by the transition phase
on days 2–4, and senescence on days 5–6. The activation
of autophagy peaks in the transition phase of senescence
and correlates with down-regulation of mammalian tar-
get of rapamycin (mTOR) and cell cycle exit. Surprisingly,
Young et al. (2009) found a subset of autophagy-related
genes (ATG) are up-regulated in senescence, including
ULK3, LC3B, BNIP3, and BNIP3L. ULK3 is one of the
three mammalian homologs of yeast ATG1 that encodes
a protein kinase responsible for activating autophagy,
LC3B encodes an autophagosome component, and BNIP3
and BNIP3L encode proteins important for directing
mitochondria to autophagosomes for degradation. ATG
genes were initially suppressed in the mitotic phase then
up-regulated in the transition phase, correlating with in-
hibition ofmTOR and induction of the transcription factor
FoxO3a that induces ATG gene expression. Importantly,
the coincidence of increased autophagy with cellular
senescence is not limited to cell culture settings involving
oncogene overexpression. Hence, chemically induced skin
papillomas, which harbor activated ras mutations and are
loaded with senescent cells (Collado et al. 2005), also show
high autophagic activity (Young et al. 2009).
Although these are interesting associations, the signif-
icance of autophagy induction during OIS was revealed
with autophagy inhibition, which delayed senescence
and the accumulation of senescence-associated secreted
proteins (Young et al. 2009). Thus autophagy is an
important component of the senescence program re-
quired for efficient establishment and quality of the
senescence phenotype. It is provocative to speculate that
impairment of autophagy facilitates escape from senes-
cence, and that this contributes to the increased tumor-
igenesis that results from autophagy defects (Mathew
et al. 2007a; Levine and Kroemer 2008). Defining which
aspects of autophagy are required for senescence and if or
how this impacts tumor suppression through senescence
are the next important issues.
Is senescence-associated autophagy a specialized form
of autophagy?
Although autophagy is induced in response to a wide
variety of stresses, it is not clear that the process of
autophagy is the same in all cases. In starvation, for
example, the recycling role of autophagy may be para-
mount, whereas in response to hypoxia, the elimination
of mitochondria through autophagy to suppress oxidative
stress may bemore critical. During senescence, induction
of ULK3 was sufficient to stimulate autophagy and pre-
mature senescence (Young et al. 2009). Thus, like ULK1
and ULK2, ULK3 is an autophagy regulator. The induc-
tion of ULK3 in OIS is associated with a gene expression
signature of autophagy-related genes that is distinct from
that induced by starvation. This suggests that ULK3 and
autophagy induction in OIS may be a specialized form of
autophagy that acts to facilitate cellular remodeling.
Going forward, it will be interesting to test if different
forms of autophagy exist and how these may accomplish
their distinct objectives. Furthermore, it will be interesting
to examine if expression of specific ULKs is an essential
determinant, and what aspects of autophagy are required
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and perhaps specific for establishing the senescence
phenotype.
Role of autophagy in senescence
The current study establishes the requirement for autoph-
agy in the efficient execution of the senescence program.
Two main remaining questions are how autophagy facili-
tates senescence, and whether there is a consequence to
oncogenesis when senescence is bypassed by defects in
autophagy. While the answers to these questions are not
yet known, some potential outcomes can be extrapolated
from the current state of knowledge.
Cellular remodeling
Senescence is a remarkable cellular reprogramming event
that involves both epigenetic changes in gene expression
and cellular remodeling. Some of the changes in gene
expression during OIS are responsible for autophagy
induction. What is unusual is that the lysosomal degra-
dation of cellular components by progressive autophagy
typically results in cell shrinkage due to self-consumption
(Lum et al. 2005; Degenhardt et al. 2006). In contrast,
senescence results in the generation of large cells with
dramatically altered morphology. If senescence-associated
autophagy is a distinct process from other forms of
autophagy, it may be that specific lysosomal degradation
events are required for the physical remodeling that
generates the senescence phenotype.
Although autophagy can be a bulk degradation process,
evidence is emerging that there is also targeted degrada-
tion of cellular components though autophagy. In the case
of specific protein degradation by autophagy, polyubiqu-
tination tags proteins for recognition by the adaptor
protein p62, which directs them to autophagosomes for
degradation (Pankiv et al. 2007). Cytoskeletal proteins of
the keratin family, for example, are degraded by autoph-
agy along with p62 and accumulate aberrantly when
autophagy is defective (Komatsu et al. 2005, 2006, 2007;
Hara et al. 2006). It is possible that some of the pheno-
typic changes during senescence require targeted degra-
dation of specific cellular components, perhaps of the
cytoskeleton, to achieve efficient remodeling associated
with senescence.
Energy homeostasis and intracellular recycling
Catabolism through autophagy sustains metabolism and
viability, which is important in starvation and potentially
in situations where energy demand is high (Kuma et al.
2004; Tsukamoto et al. 2008). Oncogene activation may
increase bioenergentic stress, and the process of senes-
cence itself may increase energy demand. Senescent cells
are metabolically and biosynthetically active and secrete
inflammatory mediators essential for entry and mainte-
nance of senescence (Acosta et al. 2008; Kuilman et al.
2008; Wajapeyee et al. 2008) and immune surveillance
(Xue et al. 2007; Krizhanovsky et al. 2008). Through
intracellular recycling, autophagy provides building
blocks for macromolecular synthesis that may support
cellular metabolism for protein synthesis and secretion.
Assessment of the metabolic state of senescent cells and
autophagy dependence and identification of the specific
origin of the secretory impairment when autophagy is
suppressed should illuminate this issue.
Damage mitigation
It is clear that autophagy is required for the degradation of
polyubiquitinated proteins and organelles, that this re-
quirement is increased with stress, and that failure of this
process can lead to cell damage and death. This damage
mitigation function is likely responsible for preventing
neurodegeneration, liver damage, and cancer (Hara et al.
2006; Komatsu et al. 2006, 2007; Karantza-Wadsworth
et al. 2007; Mathew et al. 2007b). Preservation of the
health of senescent cells through autophagy damage
mitigation may be similarly important to prevent cancer
and liver fibrosis. It is not yet known if inhibition of
autophagy during senescence produces the buildup of
polyubiquitinated proteins, p62, damaged mitochondria,
and activation of the DNA damage response, but this
would be a first step toward addressing this question.
Does autophagy suppress tumorigenesis by maintaining
cellular quality control and remodeling?
Senescence is an early barrier to oncogenesis, and im-
pairment of the efficiency or quality of senescence by
autophagy defect may increase cancer incidence. The
potential role for autophagy in preventing senescence
bypass can begin to be assessed by comparing cancer
incidence following oncogene activation and induction of
OIS in mice with an autophagy wild-type and defective
(beclin1+/) genetic background. Nonetheless, the suc-
cessful management of stress is critical for tumor sup-
pression and autophagy is a fundamental part of stress
management. Stressed cells activate autophagy, which
prevents damage and maintains metabolism though ly-
sosomal turnover of cellular components (Fig. 1). Autoph-
agy can facilitate senescence or limit damage and delay
apoptosis to allow recovery of normal cell function as
tumor suppression mechanisms. In overwhelming stress,
apoptosis may independently function in tumor suppres-
sion (Fig. 1). Autophagy can thereby be thought of as
regulating cellular quality control, both of senescent and
normal cells that may ultimately limit tumorigenesis.
While there are still many unanswered questions, this
provides a unifying theme linking the stress response
pathways of senescence, autophagy, and apoptosis with
tumor suppression.
Figure 1. Role of autophagy, apoptosis, and senescence in
tumor suppression. See the text for detail.
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